DROMOLAND TRUST, LLC – Trademark Portfolio

Entity Type: 16

DROMOLAND TRUST, LLC holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 4 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include ALIVENLABS, OPC FACTOR, and CELL ESSENTIALS. The owner is based in Eagle, ID.

6063 W Hamm Ct

Eagle, ID 83616

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

DROMOLAND TRUST, LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (4 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

3
Cosmetics & Cleaning (2 filings)

Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring

Frequently Asked Questions

How many trademarks does DROMOLAND TRUST, LLC have?

DROMOLAND TRUST, LLC has 4 U.S. trademarks filed with the USPTO. Of these, 3 registered, 1 cancelled.

What trademark classes does DROMOLAND TRUST, LLC file in?

DROMOLAND TRUST, LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 3 (Cosmetics & Cleaning). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are DROMOLAND TRUST, LLC's most well-known trademarks?

DROMOLAND TRUST, LLC's registered trademark portfolio includes well-known marks such as ALIVENLABS, OPC FACTOR, and CELL ESSENTIALS. These are among 3 currently registered trademarks in the portfolio.

What is DROMOLAND TRUST, LLC's trademark registration success rate?

DROMOLAND TRUST, LLC has a 75% trademark registration rate, with 3 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.